Kathryn E. Wengel - 11 Feb 2023 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Role
Director
Signature
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Kathryn E. Wengel
Issuer symbol
LH
Transactions as of
11 Feb 2023
Net transactions value
$0
Form type
4
Filing time
14 Feb 2023, 14:11:43 UTC
Previous filing
14 Feb 2023
Next filing
15 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LH Common Stock Options Exercise +742 +123% 1,345 11 Feb 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LH Restricted Stock Unit Options Exercise $0 -742 -47% $0.000000 849 11 Feb 2023 Common Stock 742 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2 The Restricted Stock Units vested fully on February 11, 2023.
F3 This number reflects the aggregate number of Restricted Stock Units held by the reporting person.